| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |